Ambica: One in Health

Ambica: One in Health Ambica International Corp. is one of the leading local pharmaceutical companies in the Philippines. Northern Philippine Cobra (Naja Naja Philippinensis); (b.)

Ambica is currently the sole distributor of Reteplase in the Philippines and in partnership with its affiliate company - Ambitech Biopharmaceuticals Inc., they have successfully developed an anti-venom serum against snakebites. Product Description:
• Reteplase 18mg Lyophilized Powder for Solution for Intravenous Injection (MIRel) - the first 3rd Generation recombinant tissue plasminogen activator (rTPA) in the Philippines. The rationale behind the development of MIRel-Reteplase was to find a faster thrombolytic agent compared to approved dosage regimens of standard thrombolytics without increasing the risk of thrombolysis. The second aim was to find a substance with a longer effective half-life as compared to approved dosage regimens of standard thrombolytics in order to facilitate the method of administration.

• Anti-Snake Venom Serum (Taradoc) - a polyvalent enzyme refined anti-venom that can treat bites from any of the 3) snake specifies of: (a.) Southern Philippine Cobra (Naja Samarensis); and (c.) Philippine King Cobra (Ophiophagus Hannah). Some other snake species with the same toxicity level can also be treated using this polyvalent enzyme refined anti-venom as it exhibits cross-sensitivity with the other snake varieties such as the sea snake, the Philippines pit viper and the coral snakes.

Congratulations!!!! Lian D Destryer Well done on winning this prestigious award. You are an inspiration to us all. 💙
03/07/2023

Congratulations!!!! Lian D Destryer Well done on winning this prestigious award. You are an inspiration to us all. 💙

https://youtu.be/RjFvBcsuiEM
12/05/2023

https://youtu.be/RjFvBcsuiEM

Aired (May 7, 2023): Doc Nielsen Donato and his team went to Cagayan de Oro to examine how a king cobra's venom affects a mammal's blood. Watch this video. ...

25/12/2022
Finally Published:Preclinical assessment of VPEAV, a new trivalent antivenom for elapid snakebite envenoming in the Phil...
30/11/2022

Finally Published:

Preclinical assessment of VPEAV, a new trivalent antivenom for elapid snakebite envenoming in the Philippines: Proteomics, immunoreactivity land toxicity neutralization.

Snakebite incidents are prevalent in our country, with an estimated number of deaths at an average of 250 deaths in a ye...
24/02/2022

Snakebite incidents are prevalent in our country, with an estimated number of deaths at an average of 250 deaths in a year. Despite the dreading number, the availability of antivenom remains scarce.

Currently, the only known antivenom for snakebites in the Philippines is the Philippine Cobra Antivenom that is in a monovalent form and is specifically targeted to the venom of the Philippine Cobra.

It is therefore important to develop a 𝐏𝐎𝐋𝐘𝐕𝐀𝐋𝐄𝐍𝐓 𝐀𝐍𝐓𝐈𝐕𝐄𝐍𝐎𝐌 that can treat snakebites from different species with the same toxicity level.

Ambica, through Ambitech its biopharmaceutical arm, successfully developed the anti-venom* against the following snake species:
• 𝐍𝐨𝐫𝐭𝐡𝐞𝐫𝐧 𝐏𝐡𝐢𝐥𝐢𝐩𝐩𝐢𝐧𝐞 𝐂𝐨𝐛𝐫𝐚 (𝐍𝐚𝐣𝐚 𝐍𝐚𝐣𝐚 𝐏𝐡𝐢𝐥𝐢𝐩𝐩𝐢𝐧𝐞𝐧𝐬𝐢𝐬)
• 𝐒𝐨𝐮𝐭𝐡𝐞𝐫𝐧 𝐏𝐡𝐢𝐥𝐢𝐩𝐩𝐢𝐧𝐞 𝐂𝐨𝐛𝐫𝐚 (𝐍𝐚𝐣𝐚 𝐒𝐚𝐦𝐚𝐫𝐞𝐧𝐬𝐢𝐬)
• 𝐏𝐡𝐢𝐥𝐢𝐩𝐩𝐢𝐧𝐞 𝐊𝐢𝐧𝐠 𝐂𝐨𝐛𝐫𝐚 (𝐎𝐩𝐡𝐢𝐨𝐩𝐡𝐚𝐠𝐮𝐬 𝐇𝐚𝐧𝐧𝐚𝐡)

*𝑻𝒉𝒊𝒔 𝒑𝒓𝒐𝒅𝒖𝒄𝒕 𝒊𝒔 𝑵𝑶𝑻 𝑭𝑶𝑹 𝑺𝑨𝑳𝑬 𝒂𝒏𝒅 𝒊𝒔 𝒓𝒆𝒔𝒕𝒓𝒊𝒄𝒕𝒆𝒅 𝒇𝒐𝒓 𝒖𝒔𝒆 𝒐𝒏𝒍𝒚 𝒕𝒉𝒓𝒐𝒖𝒈𝒉 𝑪𝒐𝒎𝒑𝒂𝒔𝒔𝒊𝒐𝒏𝒂𝒕𝒆 𝑺𝒑𝒆𝒄𝒊𝒂𝒍 𝑷𝒆𝒓𝒎𝒊𝒕 𝒊𝒔𝒔𝒖𝒆𝒅 𝒃𝒚 𝒕𝒉𝒆 𝑭𝑫𝑨.

Mirel Activity
15/02/2019

Mirel Activity

Address

#9 Amsterdam Extension, Merville Park Subdivision
Parañaque
1709

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Ambica: One in Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Ambica: One in Health:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category